Medical Condition News

RSS

Canadians with lung, breast, colorectal or ovarian cancer have higher survival rate

Canadians with lung, breast, colorectal or ovarian cancer have a higher rate of survival than people diagnosed with these cancers in the United Kingdom, Denmark or Norway, a new international study has found.

22 Dec 2010

First implantation of Medtronic Transcatheter Aortic Valve Prosthesis in US performed at Mount Sinai

David H. Adams, MD, Marie-Jos-e and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery, Samin K. Sharma, MD, the Zena and Michael A. Weiner Professor and Director of the Cardiac Catheterization Laboratory, and Annapoorna S. Kini, MD, Associate Professor and Associate Director of the Cardiac Catheterization Laboratory at The Mount Sinai Medical Center, have performed the first implantation of the Medtronic CoreValve- Transcatheter Aortic Valve Prosthesis in the United States.

22 Dec 2010

Researchers receive $100,000 NFL grant to study tissue engineering for spinal injuries

Researchers from Cornell University and Weill Cornell Medical College have been awarded $100,000 by NFL Charities, the charitable foundation of the National Football League owners, to research tissue engineering for spinal injuries.

22 Dec 2010

Gold nanoparticles show great potential for tumour targeted drug delivery

The World Gold Council (WGC) is delighted with the successful phase 1 clinical trial of a unique nanomedicine that uses nanoparticles of gold as the core of a delivery system for tumour targeted drug delivery.

22 Dec 2010

Biogen Idec, Elan propose updated product labeling for TYSABRI to FDA and EMA

Biogen Idec and Elan Corporation, plc announced that the companies have submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMA) to request review and approval to update the respective TYSABRI Prescribing Information and Summary of Product Characteristics.

22 Dec 2010

U.S. pivotal clinical trial of Medtronic CoreValve begins

Medtronic, Inc. today announced the beginning of its Medtronic CoreValve® U.S. Pivotal clinical trial in the United States. The first CoreValve transcatheter aortic valve implantation (TAVI) procedure was performed by David H. Adams, M.D., and Samin K. Sharma, M.D., at The Mount Sinai Medical Center in New York City.

22 Dec 2010

Amorcyte reports AMR-001 phase I trial results in heart attack patients

The American Heart Journal today reported results of a clinical trial evaluating Amorcyte, lead product candidate, AMR-001 for the treatment of damaged heart muscle following acute myocardial infarction.

22 Dec 2010

Pregnant women veterans face increase risk of mental health problems

Pregnancy among women veterans who served in Iraq and Afghanistan appears to increase their risk for mental health problems such as depression, anxiety, and post-traumatic stress disorder, according to a study published in Journal of Women's Health, a peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online.

22 Dec 2010

El Camino announces first patient implant in Medtronic CoreValve clinical trial

El Camino Hospital today announced its first patient implant in the Medtronic CoreValve® U.S. Clinical Trial.

22 Dec 2010

UH scientist evaluates microRNAs as potential treatment strategy for ovarian cancer

The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.

22 Dec 2010

Altering balance among immune system cells could hold potential for T2D-associated inflammation treatment

Researchers from Boston University School of Medicine (BUSM) have demonstrated that certain T cells require input from monocytes in order to maintain their pro-inflammatory response in people with type 2 diabetes (T2D). The study also showed, for the first time, how a loss in homeostasis in this group of T cells most likely promotes chronic inflammation associated with T2D.

22 Dec 2010

CHMP recommends to grant marketing authorization for Espriet drug against PF to CPF

The Coalition for Pulmonary Fibrosis announced to more than 128,000 patients news that the first drug for the treatment of the deadly lung disease Pulmonary Fibrosis has passed a major hurdle in the European regulatory process and is likely to be approved in all 27 member countries of the European Union.

22 Dec 2010

86.9% of adults express support for melanoma genetic testing in minors

The vast majority of parents who tested positive for a genetic mutation that increases the risk of melanoma support genetic testing of their children or grandchildren.

22 Dec 2010

Pepex announces development of combined glucose monitoring and insulin delivery meter

Pepex Biomedical, Inc. has unveiled development of a next generation solution for insulin dependent diabetics which will combine regular glucose monitoring and insulin delivery for diabetes sufferers worldwide. The company is developing a complete product line of multi-function meters which allow simple testing of blood glucose levels and insulin delivery, appropriate to each glucose level measurement, all contained in a single, palm-sized unit. These meters provide anytime, anywhere tracking and treatment of diabetes.

22 Dec 2010

Moderately and morbidly obese drivers face increase risk of death during severe vehicle crashes

Moderately and morbidly obese persons face many health issues -- heart disease, diabetes, hypertension, stroke, gallbladder disease and others. Now, increased chances of dying while driving during a severe auto accident can be added to the list.

22 Dec 2010

People with type 1 diabetes could grow their own insulin-producing cells, say researchers

At the annual meeting of the American Society for Cell Biology last week in Philadelphia, researchers from Georgetown University Medical Center in Washington, D.C., announced that it may be possible for people with type 1 diabetes to grow their own insulin-producing cells, a breakthrough that could lead to a cure for the disease.

22 Dec 2010

Ontario hospital implants powerful new defibrillator

St. Michael's Hospital today became the first in Ontario to implant a small but powerful new defibrillator into a patient's chest.

22 Dec 2010

Smoking can increase pain severity in cancer patients

The relationship between smoking and cancer is well established. In a study published in the January 2011 issue of PAIN, researchers report evidence to suggest that cancer patients who continue to smoke despite their diagnosis experience greater pain than nonsmokers.

22 Dec 2010

Jazz Pharmaceutical receives USPTO patent for Xyrem oral solution

Jazz Pharmaceuticals, today announced that the United States Patent and Trademark Office has issued a patent related to Xyrem oral solution titled "Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy."

22 Dec 2010

Verizon grants will eanble heart attack patients to receive life-saving treatments more quickly

Heart attack patients can receive life-saving treatments more quickly thanks to $100,000 in grants from the Verizon Foundation to the Foundation of UMDNJ for a program that enables heart attack patients to bypass the emergency room and go directly to the cardiac catheterization laboratory at UMDNJ-The University Hospital.

22 Dec 2010

Medical Condition News

Canadians with lung, breast, colorectal or ovarian cancer have higher survival rate

First implantation of Medtronic Transcatheter Aortic Valve Prosthesis in US performed at Mount Sinai

Researchers receive $100,000 NFL grant to study tissue engineering for spinal injuries

Gold nanoparticles show great potential for tumour targeted drug delivery

Biogen Idec, Elan propose updated product labeling for TYSABRI to FDA and EMA

U.S. pivotal clinical trial of Medtronic CoreValve begins

Amorcyte reports AMR-001 phase I trial results in heart attack patients

Pregnant women veterans face increase risk of mental health problems

El Camino announces first patient implant in Medtronic CoreValve clinical trial

UH scientist evaluates microRNAs as potential treatment strategy for ovarian cancer

Altering balance among immune system cells could hold potential for T2D-associated inflammation treatment

CHMP recommends to grant marketing authorization for Espriet drug against PF to CPF

86.9% of adults express support for melanoma genetic testing in minors

Pepex announces development of combined glucose monitoring and insulin delivery meter

Moderately and morbidly obese drivers face increase risk of death during severe vehicle crashes

People with type 1 diabetes could grow their own insulin-producing cells, say researchers

Ontario hospital implants powerful new defibrillator

Smoking can increase pain severity in cancer patients

Jazz Pharmaceutical receives USPTO patent for Xyrem oral solution

Verizon grants will eanble heart attack patients to receive life-saving treatments more quickly

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News